SavaVet SafeHeart Pimobendan Chewable Tablets

Safeheart (Pimobendan) is indicated for managing the signs of mild, moderate, or severe congestive heart failure (CHF) in dogs, including those with atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM), classified under modified NYHA Classes IIa, IIIb, or IVc.

Safeheart is designed for use alongside other therapies for congestive heart failure, such as furosemide, when appropriate, based on the individual needs of the dog.

USFDA-Approved Treatment for the management of congestive heart failure in dogs.

Key Benefits:

• Dual Mode of Action:
  • Positive Inotropic Effect: Strengthens heart muscle contractility, increasing cardiac output.
  • Balanced Vasodilatory Effect: Dilates both arteries and veins, improving tissue perfusion and reducing tissue congestion.
• Reduces cardiac fatigue by enhancing heart function.
• Available in easy-to-administer chewable tablets for better palatability and convenience.

Available Formulations:

• Safeheart 5 mg – Each chewable tablet contains 5 mg of Pimobendan EP.
• Safeheart 1.25 mg – Each chewable tablet contains 1.25 mg of Pimobendan EP.

Excipients: q.s.
Colours: Iron Oxide Red NF, Iron Oxide Yellow NF
Flavours: Approved flavours for palatability.

Dosage & Administration:

• Recommended Dose: Administer orally at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight.
• The dose should be divided into two portions, approximately 12 hours apart (morning and evening), and can be adjusted using whole or half tablets as needed.
• Tablets are scored, and the dosage should be given in increments of half-tablets for accurate dosing.

Packaging:

• Bottle of 30 chewable tablets.

Safeheart offers an effective, convenient treatment option for managing congestive heart failure in dogs, helping to improve heart function and quality of life.